The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107606023 10760602 3 F 20141215 20160830 20150204 20160901 EXP DE-ROCHE-1523191 ROCHE 0.00 E F Y 86.50000 KG 20160901 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107606023 10760602 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) N 125085 865 MG SOLUTION FOR INFUSION QOW
107606023 10760602 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) THE LAST DOSE PRIOR TO SAE WAS ON 17/DEC/2014. N 125085 820 MG SOLUTION FOR INFUSION QOW
107606023 10760602 3 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) N 125085 843 MG SOLUTION FOR INFUSION QOW
107606023 10760602 4 C TAVOR EXPIDET LORAZEPAM 1 Oral 0 1 MG
107606023 10760602 5 C LAXANS (BISACODYL) BISACODYL 1 Oral AS REQUIRED 0
107606023 10760602 6 C PANTOZOL PANTOPRAZOLE SODIUM 1 Oral 0 40 MG
107606023 10760602 7 C L-THYROXIN LEVOTHYROXINE SODIUM 1 Oral 0 100 UG
107606023 10760602 8 C XARELTO RIVAROXABAN 1 Oral 0 15 MG
107606023 10760602 9 C LYRICA PREGABALIN 1 Oral 0 150 MG BID
107606023 10760602 10 C JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 0 100 MG
107606023 10760602 11 C HUMALOG MIX INSULIN LISPRO 1 Subcutaneous 0 26 IU
107606023 10760602 12 C HUMALOG INSULIN LISPRO 1 Subcutaneous 0 12 IU BID
107606023 10760602 13 C Madopar BENSERAZIDE HYDROCHLORIDELEVODOPA 1 Oral 0 62.5 MG BID
107606023 10760602 14 C RAMIPRIL. RAMIPRIL 1 Oral 0 2.5 MG
107606023 10760602 15 C SIMVASTATIN. SIMVASTATIN 1 Oral 0 20 MG
107606023 10760602 16 C TILIDIN NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE 1 Oral 0 100 MG BID
107606023 10760602 17 C IMIPRAMIN IMIPRAMINE 1 Oral AS REQUIRED 0
107606023 10760602 18 C PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) DOSAGES BETWEEN 132 MG AND 172 MG 0 QOW
107606023 10760602 19 C ONDANSETRON ONDANSETRON 1 Oral 0 8 MG
107606023 10760602 20 C FENISTIL (GERMANY) 2 Intravenous (not otherwise specified) 0 4 MG
107606023 10760602 21 C RANITIC RANITIDINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 50 MG
107606023 10760602 22 C Torasemide TORSEMIDE 1 Oral 0 10 MG TABLET
107606023 10760602 23 C Torasemide TORSEMIDE 1 Oral 0 20 MG
107606023 10760602 24 C ENTACAPONE. ENTACAPONE 1 Oral 0 20 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107606023 10760602 1 Breast cancer
107606023 10760602 4 Agitation
107606023 10760602 5 Constipation
107606023 10760602 6 Prophylaxis against gastrointestinal ulcer
107606023 10760602 7 Hypothyroidism
107606023 10760602 8 Atrial fibrillation
107606023 10760602 9 Polyneuropathy
107606023 10760602 10 Diabetes mellitus
107606023 10760602 11 Diabetes mellitus
107606023 10760602 12 Diabetes mellitus
107606023 10760602 13 Parkinson's disease
107606023 10760602 14 Hypertension
107606023 10760602 15 Hypercholesterolaemia
107606023 10760602 16 Osteoarthritis
107606023 10760602 17 Sleep disorder
107606023 10760602 18 Breast cancer
107606023 10760602 19 Nausea
107606023 10760602 22 Hypertension
107606023 10760602 24 Parkinson's disease

Outcome of event

Event ID CASEID OUTC COD
107606023 10760602 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
107606023 10760602 Anaemia of malignant disease
107606023 10760602 Anal haemorrhage
107606023 10760602 C-reactive protein increased
107606023 10760602 Circulatory collapse
107606023 10760602 Febrile neutropenia
107606023 10760602 General physical health deterioration
107606023 10760602 Pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107606023 10760602 1 20140924 0
107606023 10760602 2 20141217 0
107606023 10760602 3 20141119 0
107606023 10760602 4 20141119 20141119 0
107606023 10760602 5 201411 0
107606023 10760602 6 201408 0
107606023 10760602 7 201408 0
107606023 10760602 8 201408 0
107606023 10760602 9 201408 0
107606023 10760602 10 201408 0
107606023 10760602 11 201408 0
107606023 10760602 12 201408 0
107606023 10760602 13 201408 0
107606023 10760602 14 201408 0
107606023 10760602 15 201408 0
107606023 10760602 16 201408 0
107606023 10760602 17 201410 0
107606023 10760602 18 20140924 20141223 0
107606023 10760602 19 201411 0
107606023 10760602 20 20140924 20141223 0
107606023 10760602 21 20140924 20141223 0
107606023 10760602 22 201408 0
107606023 10760602 23 201408 0
107606023 10760602 24 201408 0